文献速递神经肿瘤

偶然发现的颅内脑膜瘤:预后因素与结局的系统评价与荟萃分析

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.
PubMed 文献 · J Neurooncol · 2019-01-17

该系统评价与荟萃分析纳入20项研究共2130例偶然发现的颅内脑膜瘤患者,评估不同管理策略的结局。诊断时采用手术者占27.3%、立体定向放射外科占22.0%、主动监测占50.7%;主动监测患者症状出现的合并风险为8.1%(95%CI 2.7-16.1),监测后干预比例为24.8%(95%CI 7.5-48.0)。作者认为诊断时即干预可能导致不必要的过度治疗,需要前瞻性数据开发风险计算器。

要点

  • 偶然发现的颅内脑膜瘤诊断时管理策略差异大:手术27.3%、立体定向放射外科22.0%、主动监测50.7%。
  • 主动监测患者症状出现的合并风险为8.1%(95%CI 2.7-16.1)。
  • 作者认为诊断时即干预可能导致不必要的过度治疗。

核心结论

  • 偶然发现的脑膜瘤管理方式差异很大;多数临床或影像学进展的患者在诊断后5年内出现进展;诊断时即干预可能导致不必要的过度治疗;需要前瞻性数据开发风险计算器以更好地指导管理策略。

研究设计与样本

  • 采用既定系统评价方法检索六个数据库至2017年9月,纳入20项研究共2130例患者,采用随机效应模型估计合并事件比例,并使用个体患者数据进行预后因素的荟萃回归。

主要发现

  • 诊断时初始管理策略为手术27.3%、立体定向放射外科22.0%、主动监测50.7%,加权平均随访49.5个月(SD=29.3)。
  • 主动监测患者症状出现的合并风险为8.1%(95%CI 2.7-16.1),相关因素为瘤周水肿(OR 8.72 [95%CI 0.35-14.90])和脑膜瘤直径≥3 cm(OR 34.90 [95%CI 5.17-160.40])。
  • 主动监测一段时间后干预的合并比例为24.8%(95%CI 7.5-48.0),加权平均至干预时间为24.8个月(SD=18.2)。
  • 计入交叉后,手术和放射外科后并发症的合并风险分别为11.8%(95%CI 3.7-23.5)和32.0%(95%CI 10.6-70.5)。
  • 手术脑膜瘤为WHO I级的合并比例为94.0%(95%CI 88.2-97.9)。

临床怎么用

  • 原文未据此给出推荐;作者结论指出诊断时即干预可能导致不必要的过度治疗,并认为需要前瞻性数据开发风险计算器以更好地指导管理策略。

局限性

  • 脑膜瘤生长定义和监测方案差异很大,妨碍了相关荟萃分析。
  • 作者结论指出需要前瞻性数据开发风险计算器以更好地指导管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Incidental discovery accounts for 30% of newly-diagnosed intracranial meningiomas. There is no consensus on their optimal management. This review aimed to evaluate the outcomes of different management strategies for these tumors. METHODS: Using established systematic review methods, six databases were scanned up to September 2017. Pooled event proportions were estimated using a random effects model. Meta-regression of prognostic factors was performed using individual patient data. RESULTS: Twenty studies (2130 patients) were included. Initial management strategies at diagnosis were: surgery (27.3%), stereotactic radiosurgery (22.0%) and active monitoring (50.7%) with a weighted mean follow-up of 49.5 months (SD = 29.3). The definition of meningioma growth and monitoring regimens varied widely impeding relevant meta-analysis. The pooled risk of symptom development in patients actively monitored was 8.1% (95% CI 2.7-16.1). Associated factors were peritumoral edema (OR 8.72 [95% CI 0.35-14.90]) and meningioma diameter ≥ 3 cm (OR 34.90 [95% CI 5.17-160.40]). The pooled proportion of intervention after a duration of active monitoring was 24.8% (95% CI 7.5-48.0). Weighted mean time-to-intervention was 24.8 months (SD = 18.2). The pooled risks of morbidity following surgery and radiosurgery, accounting for cross-over, were 11.8% (95% CI 3.7-23.5) and 32.0% (95% CI 10.6-70.5) respectively. The pooled proportion of operated meningioma being WHO grade I was 94.0% (95% CI 88.2-97.9). CONCLUSION: The management of incidental meningioma varies widely. Most patients who clinically or radiologically progressed did so within 5 years of diagnosis. Intervention at diagnosis may lead to unnecessary overtreatment. Prospective data is needed to develop a risk calculator to better inform management strategies.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Islim AI, Mohan M, Moon RDC, et al. Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol. 2019. PMID: 30656531. doi:10.1007/s11060-019-03104-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。